109 related articles for article (PubMed ID: 37480425)
1. Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region.
Waked I; Alsammany S; Tirmazy SH; Rasul K; Bani-Issa J; Abdel-Razek W; Omar A; Shafik A; Eid S; Abdelaal A; Hosni A; Esmat G
Liver Int; 2023 Oct; 43(10):2062-2077. PubMed ID: 37553777
[TBL] [Abstract][Full Text] [Related]
2. An opportunity to emphasize the relevance of laboratory medicine.
Santamaría González M; Ruiz Mínguez MÁ; Arrebola Ramírez MM; Filella Pla X; Torrejón Martínez MJ; Morell García D; Castaño López MÁ; Allué Palacín JA; Albaladejo Otón MD; Giménez Gómez N
Adv Lab Med; 2021 Aug; 2(3):432-450. PubMed ID: 37362412
[TBL] [Abstract][Full Text] [Related]
3. Current Trends and Advancements in the Management of Hepatocellular Carcinoma.
Teufel A; Kudo M; Qian Y; Daza J; Rodriguez I; Reissfelder C; Ridruejo E; Ebert MP
Dig Dis; 2024 May; ():1-12. PubMed ID: 38599204
[TBL] [Abstract][Full Text] [Related]
4. 2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations.
Kumar A; Acharya SK; Singh SP; Duseja A; Madan K; Shukla A; Arora A; Anand AC; Bahl A; Soin AS; Sirohi B; Dutta D; Jothimani D; Panda D; Saini G; Varghese J; Kumar K; Premkumar M; Panigrahi MK; Wadhawan M; Sahu MK; Rela M; Kalra N; Rao PN; Puri P; Bhangui P; Kar P; Shah SR; Baijal SS; Shalimar ; Paul SB; Gamanagatti S; Gupta S; Taneja S; Saraswat VA; Chawla YK
J Clin Exp Hepatol; 2024; 14(1):101269. PubMed ID: 38107186
[TBL] [Abstract][Full Text] [Related]
5. Statistical perspectives on using hepatocellular carcinoma risk models to inform surveillance decisions.
Innes H; Nahon P
J Hepatol; 2023 Nov; 79(5):1332-1337. PubMed ID: 37210001
[TBL] [Abstract][Full Text] [Related]
6. Ultrasonography of Hepatocellular Carcinoma: From Diagnosis to Prognosis.
Hu H; Zhao Y; He C; Qian L; Huang P
J Clin Transl Hepatol; 2024 May; 12(5):516-524. PubMed ID: 38779517
[TBL] [Abstract][Full Text] [Related]
7. INASL Consensus on Management of HCC: Navigating an Evolving Field.
Singal AG; Pillai A; Parikh ND
J Clin Exp Hepatol; 2024; 14(1):101292. PubMed ID: 38076368
[No Abstract] [Full Text] [Related]
8. Understanding the 2021 Evaluation and Management coding guidelines.
Bischof AL
Nurse Pract; 2023 Feb; 48(2):6-12. PubMed ID: 36700788
[No Abstract] [Full Text] [Related]
9. Distinct Morphological and Molecular Profiles of NAFLD and NAFLD-associated HCC Revealed by Immunohistochemistry and MicroRNA Analysis.
Rusu I; Pirlog R; Chiroi P; Nutu A; Budisan L; Puia VR; Braicu C; Berindan-Neagoe I; Al Hajjar N
J Gastrointestin Liver Dis; 2023 Sep; 32(3):356-366. PubMed ID: 37494555
[TBL] [Abstract][Full Text] [Related]
10. Public knowledge and attitudes toward liver diseases and liver cancer in the Brazilian population: a cross sectional study.
Bittencourt PL; Codes L; Cesar HF; Gomes Ferraz ML
Lancet Reg Health Am; 2023 Jul; 23():100531. PubMed ID: 37497393
[TBL] [Abstract][Full Text] [Related]
11. Analysis of non-alcoholic fatty liver disease during induction therapy for B-cell precursor acute lymphoblastic leukemia in children and adolescents.
Sano H; Kobayashi R; Suzuki D; Yanagi M; Hori D; Matsushima S; Kobayashi K
Pediatr Neonatol; 2024 Jan; 65(1):23-30. PubMed ID: 37482442
[TBL] [Abstract][Full Text] [Related]
12. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the current guidelines for resection of hepatocellular carcinoma using the Appraisal of Guidelines for Research and Evaluation II instrument.
Gavriilidis P; Roberts KJ; Askari A; Sutcliffe RP; Huo TL; Liu PH; Hidalgo E; Compagnon P; Lim C; Azoulay D
J Hepatol; 2017 Nov; 67(5):991-998. PubMed ID: 28690176
[TBL] [Abstract][Full Text] [Related]
14. Representations of clinical practice guidelines and health equity in healthcare literature: An integrative review.
McMillan Boyles C; Spoel P; Montgomery P; Nonoyama M; Montgomery K
J Nurs Scholarsh; 2023 Mar; 55(2):506-520. PubMed ID: 36419399
[TBL] [Abstract][Full Text] [Related]
15. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227
[TBL] [Abstract][Full Text] [Related]
16. Clinical Practice Guidelines For the Management of Hepatocellular Carcinoma: A Systematic Review.
Seth I; Siu A; Hewitt L; Budak U; Farah B; Jaber M
J Gastrointest Cancer; 2024 Mar; 55(1):318-331. PubMed ID: 37480425
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
